Login

Arina Šablinskaja

ORCID: 0000-0003-4641-2695
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5021560215
Research Areas
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Hepatitis C virus research
  • HIV/AIDS Research and Interventions

University of Tartu
 2023-2025

 Transmitted HIV-1 Drug Resistance in Estonian Residents and Ukrainian Refugees in 2020 and 2022
OPENALEX - Publications 
Arina Šablinskaja Hiie Soeorg Merit Pauskar Ene‐Ly Jõgeda Heli Rajasaar and 9 more Pilleriin Soodla Eveli Kallas Kati Hensen Jekaterina Tabri Kristi Rüütel Taavi Päll Irja Lutsar Kristi Huik Radko Avi

10.1016/j.jgar.2025.01.008 article EN cc-by-nc-nd Journal of Global Antimicrobial Resistance 2025-01-01
 No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017
OPENALEX - Publications 
Arina Šablinskaja Merit Pauskar Ene‐Ly Jõgeda Heli Rajasaar Pilleriin Soodla and 9 more Eveli Kallas Anna Velts-Lindh Ruth Küüsmaa Kai Zilmer Kristi Rüütel Taavi Päll Irja Lutsar Kristi Huik Radko Avi

In Eastern Europe, HIV-1 transmitted drug resistance (TDR) data, especially in the integrase (IN) region, are limited. Estonia, INSTI (integrase strand transfer inhibitors) TDR has been studied only prior to scale-up late 2010s. The current study aimed determine levels of protease (PR), reverse transcriptase (RT) and IN surveillance mutations (SDRMs) among newly diagnosed patients Estonia 2017. included 216 individuals from 1 January until 31 December 2017 Estonia. Demographic clinical data...

10.1016/j.jgar.2023.02.009 article EN cc-by-nc-nd Journal of Global Antimicrobial Resistance 2023-03-02
Coming Soon ...